NCT02327143View on ClinicalTrials.gov

A Study of LY2835219 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

LY2835219

Administered orally

DRUG

¹³C₈-LY2835219

Administered IV

Trial Locations (1)

LS2 9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02327143 - A Study of LY2835219 in Healthy Participants | Biotech Hunter | Biotech Hunter